HGH Market Projected to Exceed 7 Billion Annually by 2025

Recent reports show that the global market for human growth hormone is growing rapidly and projected to break 7 billion dollars in annual sales by the year 2025.

This growth is being driven by a variety of causes including increased demand in the anti-aging field, increased pituitary dysfunction diagnoses, and newly approved treatments such as chronic kidney and Creutzfeldt-Jakob disease.

Generally, HGH was used for the treatment of diseases where the human body did not produce enough naturally such as standard growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, idiopathic short stature, and small for gestational age disorders.

Now in 2018 there are a large variety of issues that are treated by via both FDA approved and off-label prescriptions such as Creutzfeldt-Jakob disease, SHOX gene haploinsufficiency, Noonan syndrome, chronic kidney disease, and generally vitality/anti-aging regimens.

A large number of practitioners now offer Human Growth Hormone injections to aging patients to help with overall well-being. While this may not be an FDA approved use case it has sky-rocketed in recent years due to the demand for both the cosmetic and health-related benefits it provides aging users.

Human growth hormone (somatotropin) is a naturally occurring peptide hormone that helps stimulate the human body to not only grow but all increase cell reproduction and cell regeneration. As humans get older the amount of HGH our bodies produce decreases overtime. This can lead to a variety of ill effects from a fitness, health, and overall wellness standpoint.

To combat this human growth hormone prescriptions and on-going treatment plans have been used. HGH treatments have been shown to increase energy levels, increase muscle mass, decrease overall body fat, and help with recovery from intense physical exercise and injuries. Due to these negative factors becoming more prevalent as people age the amount of doctors and clinics offering this solution to patients has grown exponentially over the last 10 years.

Additionally, a large number of athletes, bodybuilders, and fitness enthusiasts have started using human growth hormone to maximize their results in their said disciplines. Effects such as increased recovery, muscle mass, and strength align perfectly with the goals of said individuals thus creating a thriving off-label market for these drugs. To add to this, the difficulty in testing for this performance-enhancing substance has led many competitive athletes to consider it a great alternative to traditional drugs like anabolic steroids.

Some other factors which may be responsible for the expected market growth over the next 10 years include

1) The increased diagnoses of Growth Hormone deficiency combined with overall advancements in the fields of recombinant DNA technology. Together these changes will likely cause a strong boost to the overall HGH market.

2) The recent increased use of HGH to treat Turner syndrome has caused a large spike in overall figures.

3) The increased demand in this area has also caused a large number of large multi-national pharmaceutical companies to increase spending in the area. Some of the large names currently expanding in this field include Pfizer, Merck, Eli Lilly, and Genentech Inc. Due to this, you can see a detailed description in regards to the various types and medications currently being marketed and sold.

Due to the variety of growth drivers in the space, it’s evident that the HGH market will continue to grow at an exponential rate over the coming years.